Acute Cholangitis - Hepatobiliary Surgery Pathway (TG18)
Acute Cholangitis - Hepatobiliary Surgery Pathway (TG18): Acute Cholangitis - Hepatobiliary Referral → Hepatobiliary Assessment → TG18 Severity Grading ...
Interactive Decision Tree
Algorithm Steps
- ▶Start
Acute Cholangitis - Hepatobiliary Referral
Complex/refractory cases or ERCP failure
- ●Action
Hepatobiliary Assessment
When is HPB consultation needed?
- INDICATIONS FOR HPB CONSULT:
- - Failed ERCP (2+ attempts)
- - Complex biliary anatomy
- - Surgical etiology (bile duct injury)
- - Malignant biliary obstruction
- - Grade III (severe) cholangitis
- - Recurrent cholangitis
- ◆Decision
TG18 Severity Grading
Determines urgency
- Grade I: Mild - No organ dysfunction
- Grade II: Moderate - Risk factors
- Grade III: Severe - Organ dysfunction
- ⚠Warning
Grade III (Severe)
URGENT biliary drainage
- ANY ONE organ dysfunction:
- - Hypotension requiring pressors
- - Altered mental status
- - PaO2/FiO2 <300
- - Creatinine >2.0 mg/dL
- - INR >1.5
- - Platelets <100,000
- REQUIRES:
- - ICU admission
- - Urgent drainage (<12-24h)
- - Organ support
- ●Action
Biliary Drainage Hierarchy
HPB surgeon coordinates approach
- 1. ERCP (if not failed/contraindicated)
- - Success rate 90-95%
- 2. PTC (percutaneous transhepatic)
- - When ERCP fails
- - Proximal obstruction
- - Altered anatomy (Roux-en-Y)
- 3. EUS-guided drainage (emerging)
- 4. SURGICAL drainage (last resort)
- ●Action
PTC Drainage
When ERCP not possible
- Percutaneous transhepatic cholangiography
- INDICATIONS:
- - Failed ERCP
- - Roux-en-Y anatomy
- - Proximal obstruction (Klatskin)
- - Duodenal obstruction
- TECHNIQUE:
- - US or fluoro-guided
- - Right > left approach usually
- - External drain initially
- - Can convert to internal later
- ●Action
Definitive Source Management
After stabilization
- CHOLEDOCHOLITHIASIS:
- - CBD clearance (ERCP/surgery)
- - Cholecystectomy (interval or same admission)
- MALIGNANT STRICTURE:
- - Staging workup
- - Metal stent vs surgery
- - Oncology consultation
- BILE DUCT INJURY:
- - Hepaticojejunostomy (delayed)
- - Referral to high-volume center
- BENIGN STRICTURE:
- - Serial dilation/stenting
- - Consider surgical bypass
- ●Action
Antibiotic Management
Empiric coverage
- EMPIRIC (before cultures):
- - Pip-Tazo 4.5g IV q6h OR
- - Ceftriaxone + Metronidazole OR
- - Meropenem (if MDR risk)
- ADJUST per culture results
- DURATION:
- - 4-7 days after source control
- - Longer if undrained/bacteremia
- ●Action
Post-Drainage Surveillance
Monitor for complications
- Serial LFTs (daily until improving)
- Repeat imaging if not improving
- Drain output monitoring
- Watch for: Recurrent cholangitis, abscess, leak
- Plan for definitive surgery if needed
- ✓Outcome
Outcomes
Prognosis
- Grade I: Mortality <1%
- Grade II: Mortality 5-10%
- Grade III: Mortality 10-30%
- Delay in drainage: Increased mortality
- Surgical drainage: Higher morbidity but effective
- ⚠Warning
Surgical Biliary Drainage
When interventional approaches fail
- INDICATIONS:
- - Failed ERCP + PTC
- - Peritonitis requiring laparotomy
- - Bile duct injury requiring repair
- - Gallbladder source (cholecystectomy)
- OPTIONS:
- - CBD exploration + T-tube
- - Cholecystostomy (if high-risk)
- - Choledochojejunostomy (rare acute)
- HIGH MORBIDITY in acute setting
Guideline Source
Tokyo Guidelines 2018 (TG18) - Surgical Management of Cholangitis
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Severity may evolve rapidly
- ERCP availability varies
- Surgical drainage reserved for failed endoscopic/percutaneous
- Elderly/immunocompromised may not mount typical response
Applicable Regions
Related Hepatobiliary Surgery Pathways
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Acute Cholangitis - Hepatobiliary Surgery Pathway (TG18)?
The Acute Cholangitis - Hepatobiliary Surgery Pathway (TG18) is a emergency clinical algorithm for Hepatobiliary Surgery. It provides a structured decision tree to guide clinical decision-making, based on Tokyo Guidelines 2018 (TG18) - Surgical Management of Cholangitis.
What guideline is the Acute Cholangitis - Hepatobiliary Surgery Pathway (TG18) based on?
This algorithm is based on Tokyo Guidelines 2018 (TG18) - Surgical Management of Cholangitis (DOI: 10.1002/jhbp.518).
What are the limitations of the Acute Cholangitis - Hepatobiliary Surgery Pathway (TG18)?
Known limitations include: Severity may evolve rapidly; ERCP availability varies; Surgical drainage reserved for failed endoscopic/percutaneous; Elderly/immunocompromised may not mount typical response. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Acute Cholangitis - Hepatobiliary Surgery Pathway (TG18) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free